The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9593082 B1

PDF
Full Text
Expired
Date of Patent:
Mar. 14, 2017

Filed:

Feb. 12, 2008
Applicants:

Ankush Argade, Foster City, CA (US);

Arvinder Sran, Fremont, CA (US);

David Carroll, San Francisco, CA (US);

Jeffrey Clough, Redwood City, CA (US);

Kin Tso, San Francisco, CA (US);

Somasekhar Bhamidipati, Foster City, CA (US);

Sambaiah Thota, Fremont, CA (US);

Rajinder Singh, Belmont, CA (US);

Vanessa Taylor, San Francisco, CA (US);

Hui LI, Santa Clara, CA (US);

Esteban Masuda, Menlo Park, CA (US);

Inventors:

Ankush Argade, Foster City, CA (US);

Arvinder Sran, Fremont, CA (US);

David Carroll, San Francisco, CA (US);

Jeffrey Clough, Redwood City, CA (US);

Kin Tso, San Francisco, CA (US);

Somasekhar Bhamidipati, Foster City, CA (US);

Sambaiah Thota, Fremont, CA (US);

Rajinder Singh, Belmont, CA (US);

Vanessa Taylor, San Francisco, CA (US);

Hui Li, Santa Clara, CA (US);

Esteban Masuda, Menlo Park, CA (US);

Assignee:

Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/48 (2006.01); A61K 31/505 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 407/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01);
U.S. Cl.
CPC ...
C07D 239/48 (2013.01); A61K 31/505 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 407/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01);
Abstract

The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.


Find Patent Forward Citations

Loading…